Navigation Links
BioInformatics, LLC New Market Report - Genomics Technologies
Date:1/6/2011

ARLINGTON, Va., Jan. 6, 2011 /PRNewswire/ -- BioInformatics, LLC announces the release of their newest market report:

Genomic Technologies:  Market Insights for Life Science Suppliers (#10-005)This report is for life science suppliers who want to respond in a timely fashion to the rapidly changing market for genomic analysis products. In this study, BioInformatics LLC quantifies and characterizes the market for genetic analysis including those products used for genome-wide association studies (GWAS), copy number variation (CNV) analysis, genotyping and techniques such as microarrays, sequencing and real-time PCR.

Survey respondents indicate planned lab expenditures by vendor.  The following suppliers were provided as some of the choices in the survey: Agilent TechnologiesAffymetrixBeckman CoulterBD BiosciencesBioneerBio-RadBioTroveCepheidEppendorfGE HealthcareHelicos BioscienceIdaho Technology, Inc.IlluminaLi-Cor BiosciencesLife TechnologiesLuminexQiagenRoche Applied ScienceSequenomStratageneTechne"In this study, we look at genetic analysis in current life science laboratories, the techniques and applications used, satisfaction and unmet needs with respect to current product offerings, budgets and predicted growth and future needs among life scientists," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services.  Dr. Zemlo adds that, "The information presented in this report will provide life science suppliers with information they can use to better meet their customers' needs as the field of genetic analysis continues to expand in new directions."

To learn more about these reports, a complimentary Executive Summary is available at

http://www.gene2drug.com/index.php?page=reports&id=211

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry.  By leveraging our professional social network of more than 50,000 life scientists, we have supported more than 300 companies and provided insights that lead to better business decisions.  Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information contact:Mary FollinManager, Marketing/SalesBioInformatics, LLC2111 Wilson Blvd., Suite 250Arlington, VA  22201703.778.3080 x13 (phone)m.follin@gene2drug.com

http://www.gene2drug.com/
'/>"/>

SOURCE BioInformatics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
2. BioInformatics, LLC Studies Effective Strategies for Scientific Publishing in a Web 2.0 World
3. BioInformatics, LLC New Report -- The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III
4. BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
5. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
6. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
7. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
8. Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil
9. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
10. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
11. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life ... for the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan ... The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary ...
(Date:10/9/2017)... ... October 09, 2017 , ... ... of medical marijuana products targeting the needs of consumers who are incorporating medical ... takes place in Phoenix, Arizona. , As operators of two successful Valley dispensaries, ...
(Date:10/6/2017)... ... October 06, 2017 , ... The HealthTech Venture ... sector at their fourth annual Conference where founders, investors, innovative practitioners and collaborators ... ELEVATE pitch competition showcasing early stage digital health and med tech companies. , ...
Breaking Biology Technology:
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):